|
Volumn 68, Issue 8, 2009, Pages 1255-1259
|
The sensitivity to change for lower disease activity is greater than for higher disease activity in rheumatoid arthritis trials
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
PLACEBO;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
ARTHROPATHY;
ARTICLE;
CLINICAL ASSESSMENT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ACTIVITY;
DISEASE COURSE;
DRUG EFFICACY;
HUMAN;
JOINT SWELLING;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RHEUMATOID ARTHRITIS;
SENSITIVITY ANALYSIS;
TENDER JOINT;
TREATMENT DURATION;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
HUMANS;
MULTICENTER STUDIES AS TOPIC;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 67651230895
PISSN: 00034967
EISSN: 14682060
Source Type: Journal
DOI: 10.1136/ard.2008.092460 Document Type: Article |
Times cited : (4)
|
References (7)
|